Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer
(Q56901322)
article
article
Language:
Current Data About
Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer
(P31) |
(Q13442814)
|
||||||||
(P50) |
(Q90227155)
(Q6137574)
|
||||||||
(P304) |
347-50
|
||||||||
(P407) |
(Q1860)
|
||||||||
(P433) |
5
|
||||||||
(P478) |
5
|
||||||||
(P577) |
+2007-06-00T00:00:00Z
|
||||||||
(P921) |
(Q5452194)
(Q79460)
(Q181257)
|
||||||||
(P1433) |
(Q332266)
|
||||||||
(P1476) |
"Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer" (language: en)
|
||||||||
(P2093) |
Marc R Theoret
Philip M Arlen
Mary Pazdur
William L Dahut
|
||||||||
(P2860) |
(Q28235866)
|
other details